novared chromogen (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
96
Structured Review
Vector Laboratories
novared chromogen
Novared Chromogen, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 2015 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromogen+vector+novared+peroxidase+substrate/VECTOR+NovaRED+Peroxidase+(HRP)+Substrate+Kit/pmc13041680-242-5-7
Average 96 stars, based on 2015 article reviews
Novared Chromogen, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 2015 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromogen+vector+novared+peroxidase+substrate/VECTOR+NovaRED+Peroxidase+(HRP)+Substrate+Kit/pmc13041680-242-5-7
Average 96 stars, based on 2015 article reviews
novared chromogen - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade Article Snippet: .. In addition to detection of biomarker antibodies by use of Article Title: Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Article Snippet: .. Antibodies used included those directed against: T-cell epitopes CD3 (Abcam, Cambridge, MA, USA), CD4 (Invitrogen, Camarallo, CA, USA), CD8 (Abcam), FoxP3 for regulatory T cells (BioLegend, San Diego, CA, USA);10,11 and skin homing molecule cutaneous lymphocyte-associated antigen (CLA) (BioLegend), CD69 (Novus Biologicals, Littleton, CO, USA), and CD103 (Abcam) for resident memory T (Trm) cells.12–14 In addition to detection of biomarker antibodies by use of Labeling:Article Title: Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade Article Snippet: .. In addition to detection of biomarker antibodies by use of Article Title: Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Article Snippet: .. Antibodies used included those directed against: T-cell epitopes CD3 (Abcam, Cambridge, MA, USA), CD4 (Invitrogen, Camarallo, CA, USA), CD8 (Abcam), FoxP3 for regulatory T cells (BioLegend, San Diego, CA, USA);10,11 and skin homing molecule cutaneous lymphocyte-associated antigen (CLA) (BioLegend), CD69 (Novus Biologicals, Littleton, CO, USA), and CD103 (Abcam) for resident memory T (Trm) cells.12–14 In addition to detection of biomarker antibodies by use of Plasmid Preparation:Article Title: Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade Article Snippet: .. In addition to detection of biomarker antibodies by use of Article Title: Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Article Snippet: .. Antibodies used included those directed against: T-cell epitopes CD3 (Abcam, Cambridge, MA, USA), CD4 (Invitrogen, Camarallo, CA, USA), CD8 (Abcam), FoxP3 for regulatory T cells (BioLegend, San Diego, CA, USA);10,11 and skin homing molecule cutaneous lymphocyte-associated antigen (CLA) (BioLegend), CD69 (Novus Biologicals, Littleton, CO, USA), and CD103 (Abcam) for resident memory T (Trm) cells.12–14 In addition to detection of biomarker antibodies by use of Immunopeptidomics:Article Title: Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Article Snippet: .. Antibodies used included those directed against: T-cell epitopes CD3 (Abcam, Cambridge, MA, USA), CD4 (Invitrogen, Camarallo, CA, USA), CD8 (Abcam), FoxP3 for regulatory T cells (BioLegend, San Diego, CA, USA);10,11 and skin homing molecule cutaneous lymphocyte-associated antigen (CLA) (BioLegend), CD69 (Novus Biologicals, Littleton, CO, USA), and CD103 (Abcam) for resident memory T (Trm) cells.12–14 In addition to detection of biomarker antibodies by use of |